Germany: 31 cases of blood clots after AstraZenec vaccine

The Paul Ehrlich Institute reported that it has so far reported 31 cases of clots in the cerebral veins – also known as CVST cerebral venous sinus thrombosis – and in 19 of these cases there was a platelet deficiency.

In nine cases, people died.

With the exception of two cases, all those affected were women between the ages of 20 and 63. The two men who developed blood clots were 36 and 57, according to Hotnews, which cites Reuters.

As a result, the experts leading the vaccination campaign recommend stopping the administration of AstraZeneca serum to people under 60 years of age, leaving immunization with this vaccine only to people over 60 years of age on the books.

The draft with the experts’ recommendations is on the table of the authorities, and the German press writes that they plan to follow the advice of the researchers and will announce the discontinuation of British vaccination with serum for those under 60 years in April.

However, people who took the first dose will receive the booster, even if they are younger than this age.

Canada sets the bar at 55

Canadian experts also announced on Tuesday, March 30, that they do not recommend the administration of the AstraZeneca anti-COVID vaccine to people under 55 years of age, until it is clarified why blood clots appear in those who receive this serum, reports CNN.

“Analyzing the risk of COVID by age and taking into account that other sera developed using new technologies are available, we conclude that, in the case of those under 55 years of age, we are not sure that the benefits of the AstraZeneca vaccine outweigh the risks ”Announced the Canadian vaccination committee.

Why do blood clots appear? Researchers believe they have unraveled the mystery

German researchers believe they have found an explanation for the rare cases of blood clots reported among people vaccinated with AstraZeneca, according to the Daily Mail, citing a study published Monday in the publication “Research Square.”

The researchers say the phenomenon is similar to that which rarely occurs in a condition called heparin-induced thrombocytopenia (HIT) in those who take the drug heparin. In cases of HIT, the drug stimulates the immune system to produce platelet-activating antibodies, according to DailyMail. Scientists suspect that, in rare cases, the AstraZeneca vaccine triggers the same immune response.

The researchers advise anyone who is immunized with AstraZeneca to be alert for any bruising, swelling, or headache that begins four or more days after vaccination. If you identify any of these symptoms early on, doctors can easily treat the situation.

Three weeks ago, several European countries decided to stop vaccination with AstraZeneca due to side effects. Subsequent,
The European Medicines Agency and the World Health Organization have said the vaccine is safe.

Meanwhile, Denmark has decided to extend the suspension of the AstraZeneca serum vaccination campaign for three weeks, although the serum has been declared “safe and effective” by the European Medicines Agency and the World Health Organization.

Norway is also postponing its decision for three weeks until April 15 on a possible resumption of the use of the COVID-19 vaccine developed by AstraZeneca.

Photo: Profimedia

Read also:

He cut up his wife and threw her in the trash after she accidentally thawed a bag of potato chips. “I’m Hannibal Lecter!”

Iohannis, along with world leaders calling for a treaty to protect the world from pandemics: “No one is safe until everyone is safe.”

Cuba tests its second anti-Covid vaccine in 124,000 health workers